James J. Peters VA Medical Center, Bronx, NY, USA.
Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Spinal Cord. 2021 Aug;59(8):885-893. doi: 10.1038/s41393-021-00649-x. Epub 2021 Jun 7.
Prospective cohort study.
We aim to better understand the silent period (SP), an inhibitory counterpart to the well-known motor evoked potential (MEP) elicited by transcranial magnetic stimulation (TMS), in individuals with spinal cord injury (SCI).
Veterans Affairs Hospital in New York.
EMG responses were measured in the target abductor pollicis brevis at rest (TMS at 120% of resting motor threshold (RMT)) and during maximal effort (TMS at 110% of RMT). Participants with chronic cervical SCI (n = 9) and AB participants (n = 12) underwent between 3 and 7 sessions of testing on separate days. The primary outcomes were the magnitude and reliability of SP duration, resting and active MEP amplitudes, and RMT.
SCI participants showed significantly lower MEP amplitudes compared to AB participants. SCI SP duration was not significantly different from AB SP duration. SP duration demonstrated reduced intra-participant variability within and across sessions compared with MEP amplitudes. SCI participants also demonstrated a higher prevalence of SP 'interruptions' compared to AB participants.
In a small group of individuals with chronic cervical SCI, we confirmed the well-known findings that SCI individuals have lower TMS evoked potential amplitudes and a tendency toward higher TMS motor thresholds relative to able-bodied controls. We did not observe a significant difference in SP duration between individuals with versus without SCI. However, SP duration is a more reliable outcome within and across multiple sessions than MEP amplitude.
前瞻性队列研究。
我们旨在更好地了解脊髓损伤(SCI)个体中的静息期(SP),这是经颅磁刺激(TMS)诱发的众所周知的运动诱发电位(MEP)的抑制对应物。
纽约退伍军人事务医院。
在休息时(TMS 为 120%静息运动阈值(RMT))和最大努力时(TMS 为 110%RMT),在目标外展拇指短肌中测量肌电图反应。9 名慢性颈 SCI 参与者(SCI 组)和 12 名 AB 参与者(AB 组)在不同日子进行了 3 到 7 次测试。主要结局指标是 SP 持续时间、休息和活动 MEP 幅度以及 RMT 的幅度和可靠性。
SCI 参与者的 MEP 幅度明显低于 AB 参与者。SCI SP 持续时间与 AB SP 持续时间无显著差异。与 MEP 幅度相比,SP 持续时间在个体内和个体间测试中表现出较低的个体内变异性。与 AB 参与者相比,SCI 参与者的 SP 中断发生率也更高。
在一小群慢性颈 SCI 个体中,我们证实了 SCI 个体的 TMS 诱发潜力幅度较低且 TMS 运动阈值相对于健全对照组较高的已知发现。我们没有观察到 SCI 个体与非 SCI 个体之间 SP 持续时间存在显著差异。然而,与 MEP 幅度相比,SP 持续时间是一种在多个测试中更可靠的结果。